£105.71

Wiley Cancer Gene Therapy by Viral and Non-viral Vectors: 4 (Translational Oncology)

9781118501627

Price data checked 7 days ago

View at Amazon

Price History & Forecast

Last 84 days • 84 data points (No recent data available)

Historical
Generating forecast...
£110.02 £101.99 £103.74 £105.49 £107.25 £109.00 £110.75 10 February 2026 02 March 2026 23 March 2026 13 April 2026 04 May 2026

Price Distribution

Price distribution over 84 days • 3 price levels

Days at Price
Current Price
7 days 62 days · current 15 days 0 16 31 47 62 £103 £106 £110 Days at Price

Price Analysis

Most common price: £106 (62 days, 73.8%)

Price range: £103 - £110

Price levels: 3 different prices over 84 days

Description

Provides expert, state-of-the-art insight into the current progress of viral and non-viral gene therapy Translational medicine has opened the gateway to the era of personalized or precision medicine. No longer a one-size-fits-all approach, the treatment of cancer is now based on an understanding of underlying biologic mechanisms and is increasingly being tailored to the molecular specificity of a tumor. This book provides a comprehensive overview of the pertinent molecular discoveries in the cancer field and explains how these are being used for gene-based cancer therapies. Designed as a volume in the Translational Oncology book series, Cancer Gene Therapy by Viral and Non-viral Vectors deals with the practice of gene-therapy, with reference to vectors for gene expression and gene transfer, as well as viral therapy. It covers the history and current and future applications of gene transfer in cancer, and provides expert insight on the progress of viral and non-viral gene therapy with regard to delivery system, vector design, potential therapeutic genes, and principles and regulations for cancer gene therapy. Presented in three parts, Cancer Gene Therapy by Viral and Non-viral Vectors covers: Delivery Systems • Translational Cancer Research: Gene Therapy by Viral and Non-viral Vectors • Retroviruses for Cancer Therapy • DNA Plasmids for Non-viral Gene Therapy of Cancer • Cancer Therapy with RNAi delivered by Non-viral Membrane/Core Nanoparticles Targeted Expression • Cancer Gene Therapy by Tissue-specific and Cancer-targeting Promptors • MicroRNAs as Drugs and Drug Targets in Cancer Principles of Clinical Trials in Gene Therapy • Regulatory issues for Manufacturers of Viral Vectors and Vector-transduced Cells for Phase I/II Trials • US Regulations Governing Clinical Trials in Gene Therapy • Remaining Obstacles to the Success of Cancer Gene Therapy Focusing on speeding the process in clinical cancer care by bringing therapies as quickly as possible from bench to bedside, Cancer Gene Therapy by Viral and Non-viral Vectors is an absolutely vital book for physicians, clinicians, researchers, and students involved in this area of medicine.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Nonclinical Evaluation Studies of Cellular and Gene Therapy Products: Strategies, Models, and Regulatory Frameworks
81% match

Nonclinical Evaluation Studies of Cellular and Gene Therapy Products: Strategies, Models, and Regulatory Frameworks

Elsevier

£265.99 10 May 2026
MicroRNAs in Cancer Translational Research
81% match

MicroRNAs in Cancer Translational Research

Springer

£129.92 10 May 2026
Precision Medicine in Oncology
80% match

Precision Medicine in Oncology

Wiley-Blackwell

£132.63 04 May 2026
Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)
80% match

Gynecological Cancers: Genetic and Epigenetic Targets and Drug Development (Current Clinical Oncology)

Springer

£71.91 04 May 2026
Experimental and Applied Immunotherapy
80% match

Experimental and Applied Immunotherapy

Humana

£140.31 04 May 2026
From Genome to Therapy: Integrating New Technologies with Drug Development: 229 (Novartis Foundation Symposia)
79% match

From Genome to Therapy: Integrating New Technologies with Drug Development: 229 (Novartis Foundation Symposia)

Wiley

£3.74 04 May 2026
Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies
78% match

Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies

Wiley

£131.04 04 May 2026
Transcription Factors: Normal and Malignant Development of Blood Cells (Wiley-Liss Publication)
78% match

Transcription Factors: Normal and Malignant Development of Blood Cells (Wiley-Liss Publication)

Wiley

£140.00 04 May 2026
78% match

Precision Nanomedicine: Integrating AI Technology, Nano-Delivery and Advanced Models (Nanotechnology in Biomedicine)

Elsevier

£207.99 10 May 2026
77% match

Nanodynamic Therapies: Principles and Applications (Micro and Nano Technologies)

Elsevier

£211.99 10 May 2026
Quantum Chemistry Methods for Oncological Drugs
77% match

Quantum Chemistry Methods for Oncological Drugs

Elsevier

£133.05 04 May 2026
Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)
77% match

Non-Small Cell Lung Cancer: New Research (Cancer Etiology, Diagnosis and Treatments)

£65.70 04 May 2026
Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)
77% match

Regulation of Cancer Immune Checkpoints: Molecular and Cellular Mechanisms and Therapy: 1248 (Advances in Experimental Medicine and Biology, 1248)

Springer

£137.00 04 May 2026
The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)
77% match

The Heterogeneity of Cancer Metabolism: 1311 (Advances in Experimental Medicine and Biology, 1311)

Springer

£40.29 04 May 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
77% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 11 May 2026
77% match

Multidisciplinary Interventional Oncology

Academic Press

£254.99 10 May 2026
Cell Signaling & Molecular Targets in Cancer
77% match

Cell Signaling & Molecular Targets in Cancer

Springer

£107.98 04 May 2026
Clinical Oncology and Error Reduction
77% match

Clinical Oncology and Error Reduction

Wiley

£76.44 04 May 2026
Practical Oncologic Molecular Pathology: Frequently Asked Questions (Practical Anatomic Pathology)
76% match

Practical Oncologic Molecular Pathology: Frequently Asked Questions (Practical Anatomic Pathology)

Springer

£111.22 10 May 2026
Genetic Instability and Tumorigenesis: 221 (Current Topics in Microbiology and Immunology, 221)
76% match

Genetic Instability and Tumorigenesis: 221 (Current Topics in Microbiology and Immunology, 221)

Springer

£72.98 11 May 2026
Clinical Ophthalmic Oncology: Retinoblastoma
76% match

Clinical Ophthalmic Oncology: Retinoblastoma

Springer

£70.21 04 May 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
76% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.64 04 May 2026
Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider
76% match

Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider

Springer

£80.23 04 May 2026
Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)
76% match

Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach (Pediatric Oncology)

Springer

£104.18 04 May 2026